References
- Hitzler J K, Zipursky A. Origins of leukaemia in children with Down syndrome. Nat Rev Cancer 2005; 5: 11–20
- Magalhaes I Q, Splendore A, Emerenciano M, Figueiredo A, Ferrari I, Pombo-de-Oliveira M S. GATA1 mutations in acute leukemia in children with Down syndrome. Cancer Genet Cytogenet 2006; 166: 112–116
- Wechsler J, Greene M, McDevitt M A, Anastasi J, Karp J E, Le Beau M M, et al. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat Genet 2002; 32: 148–152
- Vyas P, Crispino J D. Molecular insights into Down syndrome-associated leukemia. Curr Opin Pediatr 2007; 19: 9–14
- Xiao W, Oefner P J. Denaturing high-performance liquid chromatography: a review. Hum Mutat 2001; 17: 439–474
- Lilleberg S L, Durocher J, Sanders C, Walters K, Culver K. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform. Ann N Y Acad Sci 2004; 1022: 250–256
- Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, et al. Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood 2003; 102: 981–986
- Bain B J. A beginner's guide to blood cells, 2nd edn. Blackwell Science, London 2004
- Miller S A, Dykes D D, Polesky H F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215
- Amorim M R, Vargas F R, Llerena J C, Jr, Pombo-de-Oliveira M S. DNA extraction from fixed cytogenetic cell suspensions. Genet Mol Res 2007; 6: 500–503
- Del Vecchio C G, Giordani L, De Santis A, De Mattia D. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1. Acta Haematol 2005; 114: 113–116
- Harigae H, Xu G, Sugawara T, Ishikawa I, Toki T, Ito E. The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome. Blood 2004; 103: 3242–3243
- Pine S R, Guo Q, Yin C, Jayabose S, Druschel C M, Sandoval C. Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 2007; 110: 2128–2131
- Splendore A, Magalhaes I Q, Pombo-de-Oliveira M S. GATA1 mutations in myeloproliferative disorders: nomenclature standardization and review of the literature. Hum Mutat 2005; 26: 390–392
- Carpenter E, Valverde-Garduno V, Sternberg A, Mitchell C, Roberts I, Vyas P, et al. GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder. Br J Haematol 2005; 128: 548–551
- Hung C C, Su Y N, Lin C Y, Chang Y F, Chang C H, Cheng W F, et al. Comparison of the mismatch-specific endonuclease method and denaturing high-performance liquid chromatography for the identification of HBB gene mutations. BMC Biotechnol 2008; 8: 62
- Nichols K E, Crispino J D, Poncz M, White J G, Orkin S H, Maris J M, et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nat Genet 2000; 24: 266–270
- Groet J, McElwaine S, Spinelli M, Rinaldi A, Burtscher I, Mulligan C, et al. Acquired mutations in GATA1 in neonates with Down's syndrome with transient myeloid disorder. Lancet 2003; 10(361(9369))1617–1620
- Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003; 15(102)2960–2968